Investment advisers often have robust compliance testing programs in place to ensure their staff and control environment remains a well-oiled machine. Most of the time, such testing programs are front of mind and on top of the daily, weekly, or monthly to-do list. During 2020 and the peak of the pandemic, firms may have opted to defer their compliance testing as they adjusted to the many ramifications of Covid-19.
With the mass distribution of the vaccine, daily life has started to transition back to normal. Accordingly, compliance professionals and firms will need to regain consistency with regular forensic testing and/or stress testing of their compliance programs.
To help you get started, we’ve developed an action plan to guide you through the key questions to ask as you get started on your existing testing plan or developing one.
This list is not intended to be exhaustive; testing should always be tailored to your firm’s specific risks.
If you've fallen behind on your annual testing mandate or need help getting started, ACA’s team can help determine testing needs, perform testing, analyze the results, and determine the best path forward if enhancements are needed.
Failing to meet testing mandates can subject a firm to regulatory exposure by allowing mal- or misfeasance to continue unnoticed, and invite scrutiny from regulators, internal governance functions, and investors alike. ACA has significant experience in helping managers of all sizes to supplement their internal testing efforts and meet annual deadlines.
For questions or to discuss how ACA can help your firm strengthen its testing program, complete your testing requirements, and ensure your regulatory obligations are met, reach out to your ACA consultant or contact us here.